Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02875288 · ClinicalTrials.gov registry record · NA
Trial of Liposomal Versus Plain Bupivacaine in Minimally Invasive General Surgery Procedures
A NA study, sponsored by United States Naval Medical Center, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT02875288 is a NA study that has completed, run by United States Naval Medical Center, San Diego. The registered enrollment target is 100 participants.
The verdict
NCT02875288, a NA study, has completed, sponsored by United States Naval Medical Center, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
Aim: To compare the postoperative outcomes after surgical infiltration with plain bupivacaine compared to liposomal bupivacaine in patients undergoing elective, minimally invasive, general surgery procedures. To the investigators knowledge, there are no head-to-head, prospective, randomized, controlled trials of plain bupivacaine versus liposomal bupivacaine to evaluate postoperative pain and return of function.
Interventions
- DRUG liposomal bupivicaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2015-12 |
| Est. Completion | 2020-01-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02875288
The ClinicalTrials.gov registry entry for NCT02875288 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is United States Naval Medical Center, San Diego, which has 41 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which liposomal bupivicaine is the first listed.
NCT02875288 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02875288 about?
NCT02875288 is a clinical study titled "Trial of Liposomal Versus Plain Bupivacaine in Minimally Invasive General Surgery Procedures". Aim: To compare the postoperative outcomes after surgical infiltration with plain bupivacaine compared to liposomal bupivacaine in patients undergoing elective, minimally invasive, general surgery procedures. To the investigators knowledge, there are no head-to-head, prospective, randomized, control...
What is the current status of trial NCT02875288?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2015-12. Estimated completion is 2020-01-06.
What interventions are being tested in trial NCT02875288?
The interventions under investigation include: liposomal bupivicaine (DRUG).
Who is sponsoring clinical trial NCT02875288?
This trial is sponsored by United States Naval Medical Center, San Diego, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.